Sidekick Health is a digital health and therapeutics innovator founded by two passionate medical doctors on a mission to improve the health of humanity. Sidekick provides a uniquely wide range of digital health programs (including oncology, cardiovascular, metabolic, inflammatory, and other chronic conditions), engaging and empowering people to make positive changes, and improve their health outcomes and quality of life. Sidekick’s Adaptive CarePaths combine multiple programs into one, enabling multi-chronic care to support the growing number of people living with multiple chronic conditions. Sidekick works with health insurers, including the largest U.S. health insurer, and pharmaceutical companies, including Eli Lilly and Pfizer, to improve patient outcomes, drive clinical efficiency, and lower the cost of care. Sidekick currently operates in multiple global markets and across the U.S., including patients in all insurance classes (Medicare, Medicaid, and Commercial). Sidekick has offices in Reykjavik and Hamburg.
$55M sweet spot round size
$55M
from 2 investors over 1 rounds
Sidekick Health raised $55M on June 5, 2022
Investors: Novator and + 2 Other investors